The Clinical Operations and Development team at Pharnext is responsible for designing, implementing, and managing clinical trials for the company's lead products, including PXT3003 and PXT864. This team works to ensure the trials are conducted in compliance with regulatory standards, oversees data collection and analysis, and collaborates with international investigators to facilitate successful trial completion. Their goal is to advance the clinical development pipeline efficiently and safely, contributing to the overall mission of developing innovative treatments for neurological diseases.
View all